The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.

Braat J, Trichy NS, Holic LJ, Olivares S, Bahrami A, Balamurugan T, Barnhill R, Blokx WAM, Busam KJ, Cerroni L, Cook M, Duncan L, Elder D, Ferguson P, Ferrara G, Ko J, Landman G, Lezcano C, Lowe L, Massi D, Mihic-Probst D, Parker D, Sargen M, Scolyer R, Shea C, Spatz A, Tetzlaff M, Torres-Cabala CA, Tron V, Yeh I, Yun SJ, Zembowicz A, Gerami P

Open source

DOI
10.1016/j.humpath.2026.106103
Published
2026 Jun
Container
Human pathology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.humpath.2026.106103,
  title = {The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.},
  author = {Braat J and Trichy NS and Holic LJ and Olivares S and Bahrami A and Balamurugan T and Barnhill R and Blokx WAM and Busam KJ and Cerroni L and Cook M and Duncan L and Elder D and Ferguson P and Ferrara G and Ko J and Landman G and Lezcano C and Lowe L and Massi D and Mihic-Probst D and Parker D and Sargen M and Scolyer R and Shea C and Spatz A and Tetzlaff M and Torres-Cabala CA and Tron V and Yeh I and Yun SJ and Zembowicz A and Gerami P},
  year = {2026},
  journal = {Human pathology},
  doi = {10.1016/j.humpath.2026.106103},
  url = {https://doi.org/10.1016/j.humpath.2026.106103}
}

RIS

TY  - JOUR
TI  - The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.
AU  - Braat J
AU  - Trichy NS
AU  - Holic LJ
AU  - Olivares S
AU  - Bahrami A
AU  - Balamurugan T
AU  - Barnhill R
AU  - Blokx WAM
AU  - Busam KJ
AU  - Cerroni L
AU  - Cook M
AU  - Duncan L
AU  - Elder D
AU  - Ferguson P
AU  - Ferrara G
AU  - Ko J
AU  - Landman G
AU  - Lezcano C
AU  - Lowe L
AU  - Massi D
AU  - Mihic-Probst D
AU  - Parker D
AU  - Sargen M
AU  - Scolyer R
AU  - Shea C
AU  - Spatz A
AU  - Tetzlaff M
AU  - Torres-Cabala CA
AU  - Tron V
AU  - Yeh I
AU  - Yun SJ
AU  - Zembowicz A
AU  - Gerami P
PY  - 2026
JO  - Human pathology
DO  - 10.1016/j.humpath.2026.106103
UR  - https://doi.org/10.1016/j.humpath.2026.106103
ER  - 

APA

J, B., NS, T., LJ, H., S, O., A, B., T, B., R, B., WAM, B., KJ, B., L, C., M, C., L, D., D, E., P, F., G, F., J, K., G, L., C, L., L, L., D, M., D, M., D, P., M, S., R, S., C, S., A, S., M, T., CA, T., V, T., I, Y., SJ, Y., A, Z., & P, G. (2026). The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors.. Human pathology. https://doi.org/10.1016/j.humpath.2026.106103

Source records